Mandate

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.

The offering price amounted to EUR 13.25 per share, corresponding to a total market capitalisation of Verisure of EUR 13.7 billion (approximately SEK 150 billion) following completion of the IPO. The offering, which comprised an offering to the general public in Sweden and an offering to institutional investors in Sweden and abroad, consisted of an issuance of new shares and a sale of existing shares. The total value of the offering, assuming that the overallotment option is exercised in full, amounts to approximately EUR 3.6 billion (approximately SEK 39 billion), making it the largest IPO in Sweden in 25 years and the largest IPO in Europe in three years.

Verisure is the leading provider of professionally monitored security services in Europe and Latin America. As of 30 June 2025, more than 5.8 million families and small businesses place their trust in the Company. Verisure provides professional installation, 24/7 monitoring, expert verification and response, customer care, maintenance, and technical support, protecting against intrusion, burglary, fire, physical attack, theft, life-threatening emergencies, and other hazards. Around 90% of total revenue for the year ended 31 December 2024 came from recurring subscriptions.

Vinge’s team primarily consisted of Jesper Schönbeck, Amanda Knutsson, David Andersson, Anna Svensson, Lorin Arabi, Filip Magnusson, Carl Lexenberg and Vilma Henricsson (Capital Markets and Public M&A), Jonas Bergström, Filip Öhrner, Robin Sultani, Fredrik Eriksson Oppliger and Saga Meyer Viklund (Corporate), Albert Wållgren, Linn Adelwald, Felix Möller and Rebecka Margolin (Banking and Finance), Daniel Wendelsson and Fredrik Hellström (FDI), Martin Boström, Gabriel Pålsson and Ian Jonson (Corporate Commercial and IP) and Sam Seddigh (Employment).

Related

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026

Vinge advises Revivo Group on acquisition of Haapanen

Revivo Group, a comprehensive provider of qualified surface treatment services, has acquired Haapanen, a well-established Finnish specialist company.
January 14, 2026

Vinge advises Morrow Bank in connection with cross-border merger and list change from Oslo Børs to Nasdaq Stockholm

Vinge has advised Morrow Bank in connection with its reverse cross-border merger, whereby Morrow Bank AB is taking over Morrow Bank ASA. The Norwegian bank was previously listed on the Oslo Stock Exchange which was today transferred to Nasdaq Stockholm. Vinge has previously assisted Morrow Bank in obtaining a Swedish banking licence.
January 12, 2026